Matches in Nanopublications for { ?s ?p "DDI between Indinavir and Silodosin - Indinavir is a strong inhibitor of CYP3A4 may increase the serum concentration of silodosin by decreasing its metabolism thus increases the potential for adverse side effects. Combination therapy is contraindicated. [drugbank_resource:DB00224_DB06207]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00224_DB06207 label "DDI between Indinavir and Silodosin - Indinavir is a strong inhibitor of CYP3A4 may increase the serum concentration of silodosin by decreasing its metabolism thus increases the potential for adverse side effects. Combination therapy is contraindicated. [drugbank_resource:DB00224_DB06207]" assertion.